Lawsonia intracellularis vaccine
CA 2365494 A1 · Owner: Akzo Nobel N.V. · Inventors: Vermeij, Paul; Jacobs, Antonius Arnoldus Christiaan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates i.a. to nucleic acid sequences encoding novel Lawsonia, intracellularis proteins. It furthermore relates to DNA fragments recombinant , DNA, molecules and live recombinant carriers comprising these sequences. Also it relates to, host cells comprising such nucleic acid sequences DNA fragments, recombinant , DNA, molecules and live recombinant carriers. Moreover the invention relates to , proteins, encoded by these nucleotide sequences. The invention also relates to vaccines for, combating Lawsonia intracellularis infections and methods for the preparation thereof. Finally the invention relates to diagnostic tests for the detection of Lawsonia, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 18, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 18, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 18, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.